How did a chemistry PhD become one of the 50 most powerful women in business by hooking up the world's largest computer company with the life sciences? Kate McDonald spoke to IBM's Carol Kovac, who admits to being rather excited about the world of biology.

Cochlear boss Chris Roberts has spent 30 years at Australia's leading device companies -- but that doesn't mean he has stopped learning, as Helen Schuller discovers.

Kevin Davies spoke with Jonathan Rothberg, the founder of 454 Life Sciences, on the eve of the publication of his company's landmark paper in Nature.

Australian Biotechnology News editor-in-chief Iain Scott spoke with renowned industry analyst Cynthia Robbins-Roth about what it will take to keep biotech alive.

Ruth Beran discovers how one of Australia's great bioentrepreneurs has moved from inspiring shareholders to inspiring a nation.

The thing about bioinformatics, according to Prof Terry Speed, is that it tends to attract people from a variety of disciplines, such as physicists with programming skills not interested in a career in defence, or mathematicians with a practical bent.

When Eric Jakobsson took a new job with the National Institutes of Health, part of the agreement was that he would split his weeks between Bethesda, Maryland, and his job at the University of Illinois, jetting back and forth between the two.

History students and trivia buffs in the distant future time will be grateful for one of history's little coincidences -- the Human Genome Project will be completed this year, 2003, a neat half-century after the elucidation of the structure of DNA.

Nobel Laureate Prof Peter Doherty is lending his name to a new prize to be awarded at Australia's first Commercialisation Forum and Fair of Ideas, which started in Sydney today and runs to March 28.

Phil Batterham is a skilled and meticulous organiser, with an understanding of the value of theatre. When the University of Melbourne geneticist flew to Beijing in 1998 for the 18th International Congress of Genetics, he had already spent two years organising Australia's bid to bring the world's biggest genetics festival to Melbourne in 2003.

Interviewing Kari Stefansson -- the profane, philosophical, and hot-tempered founder, president, and CEO of Icelandic genomic company deCODE Genetics -- is not for the faint-hearted.